Hyde Park Capital announces that its client, Emerald Coast Infectious Disease (“ECID”), a full-service provider of infectious disease care, infusion services, and wound care treatment located in Fort Walton Beach and Crestview, FL, has been acquired by RCap Equity Partners (“RCap”), a middle-market private equity firm based in Wayne, PA. Emerald Coast Infectious Disease, founded 17 years ago by Dr. Patrick Anastasio, is the premier provider of infectious disease care in the Emerald Coast of Florida. ECID specializes in the treatment of diseases such as MRSA, Tuberculosis, HIV/AIDS, HepC, travel health, tropical diseases, and common infections of the skin, lungs, kidneys, bones, and blood.
Read the full article: RCap Equity Acquires Emerald Coast Infectious Disease //
Source: https://hydeparkcapital.com/press-release/hyde-park-capital-advises-emerald-coast-infectious-disease-on-its-sale-to-rcap-equity/